Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03063398 · ClinicalTrials.gov registry record
Post Acute Pancreatitis Pancreatic Exocrine Insufficiency
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 196
- Enrollment target
NCT03063398 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 196 participants.
The verdict
NCT03063398 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 196 participants
- Enrollment target
Study Summary
This study is a proposed a comprehensive prospective assessment of exocrine pancreatic insufficiency (EPI), nutritional status, and quality of life (QOL) during the early re-feeding phase, at 3 months, and 12 months following an AP attack.
Interventions
- DIAGNOSTIC_TEST No intervention, this is an observational study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2017-06-21 |
| Est. Completion | 2024-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03063398
The ClinicalTrials.gov registry entry for NCT03063398 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention, this is an observational study is the first listed.
NCT03063398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03063398 about?
NCT03063398 is a clinical study titled "Post Acute Pancreatitis Pancreatic Exocrine Insufficiency". This study is a proposed a comprehensive prospective assessment of exocrine pancreatic insufficiency (EPI), nutritional status, and quality of life (QOL) during the early re-feeding phase, at 3 months, and 12 months following an AP attack.
What is the current status of trial NCT03063398?
This trial is currently completed. The enrollment target is 196 participants. The study started on 2017-06-21. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT03063398?
The interventions under investigation include: No intervention, this is an observational study (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03063398?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.